UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Raises Stake in Mettler-Toledo International, Inc. $MTD

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 42.0% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 305,722 shares of the medical instruments supplier’s stock after buying an additional 90,395 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC’s holdings in Mettler-Toledo International were worth $361,030,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. WPG Advisers LLC purchased a new position in Mettler-Toledo International in the first quarter worth about $41,000. Zions Bancorporation National Association UT purchased a new position in Mettler-Toledo International in the first quarter worth about $43,000. Golden State Wealth Management LLC raised its holdings in Mettler-Toledo International by 583.3% in the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier’s stock worth $48,000 after buying an additional 35 shares during the last quarter. Menard Financial Group LLC purchased a new position in Mettler-Toledo International in the fourth quarter worth about $67,000. Finally, Blue Trust Inc. raised its holdings in Mettler-Toledo International by 520.0% in the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier’s stock worth $73,000 after buying an additional 52 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the company’s stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the sale, the insider directly owned 94 shares of the company’s stock, valued at approximately $123,012.16. This represents a 63.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the sale, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at approximately $6,750,875. This represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,827 shares of company stock valued at $2,371,208. Insiders own 1.94% of the company’s stock.

Analyst Upgrades and Downgrades

MTD has been the subject of several recent analyst reports. Citigroup lifted their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a report on Thursday, August 21st. Robert W. Baird lifted their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Barclays assumed coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 price target for the company. Evercore ISI reduced their price target on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating for the company in a research note on Monday, August 4th. Finally, Bank of America lifted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a “neutral” rating in a research note on Thursday, June 26th. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, Mettler-Toledo International has a consensus rating of “Moderate Buy” and an average target price of $1,311.11.

Mettler-Toledo International Stock Down 2.4%

Shares of MTD stock opened at $1,253.87 on Thursday. The company has a 50 day moving average price of $1,256.54 and a 200-day moving average price of $1,186.62. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,521.01. The firm has a market capitalization of $25.83 billion, a PE ratio of 31.75, a P/E/G ratio of 3.86 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same period in the previous year, the business posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.